Label: FEMININE ANTI ITCH CREAM- benzocaine,resorcinol cream

  • NDC Code(s): 69396-183-01, 69396-183-33
  • Packager: TRIFECTA PHARMACEUTICALS USA LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated May 1, 2026

If you are a consumer or patient please visit this version.

  • Active ingredients

    Benzocaine 20%

    Resorcinol 3%

  • Purpose

    External Analgesic

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

  • INDICATIONS & USAGE

    Uses Temporarily relieves itching.

  • Directions

    Adults and children 12 years and older

    Apply a fingertip amount, approximately 1 inch strip to affected area not more than 3 to 4 times daily. Clean nozzle of tube by wiping thoroughly before replacing cap. Keep cap tightly closed between uses.

  • Inactive Ingredients

    Inactive ingredient Acrylates (C-10-30)alkyl acrylate crosspolymer, Aloe barbadensis leaf juice, aminomethyl propanol, cetyl alcohol,

    Glyceryl stearate, Isopropyl myristate, isopropyl palmitate, lanolin, methylparaben, PEG-100 stearate, Potassium cetyl phosphate, Propylene glycol, Retinyl palmitate, sdium sulfite, tocopheryl acetate, Trisodium HEDTA, vitamin D3, water, Zea mays (corn) oil.

  • Stop Use and ask Doctor

    Stop Use and ask doctor is condition worsens or if symptoms persist for more than 7 days or clear up and occur again within a few days.

  • Other information


    ● store at 20° to 25°C ( 68° to 77°F)

    .

  • Warning

    For External Use Only

    When using avoid contact with eyes.

  • QUESTIONS

    Questions? Call 1-888-296-9067

  • SPL UNCLASSIFIED SECTION

    Distributed by:

    Trifecta Pharmaceuticals USA™

    101 NE Third Avenue, Suite 1500

    Ft. Lauderdale, FL 33301, USA

    1-888-296-9067

    This product is not manufactured or distributed by Combe Incorporated, owner of the registered trademark Vagasil®

  • Do Not Use

    Do not use this product if youhave a history of allergy to local anesthetics such as procaine, butacaine, benzocaine or other caine anesthetics.

  • Packagte Label

    4012-FBA Globe Feminine Anti Itch Cream 1oz 041626 CDER

  • Package Label

    401203-FBA Globe Feminine Anti Itch Cream 1oz 3pk box 041626 CDER

  • INGREDIENTS AND APPEARANCE
    FEMININE ANTI ITCH CREAM 
    benzocaine,resorcinol cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69396-183
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE20 g  in 100 g
    RESORCINOL (UNII: YUL4LO94HK) (RESORCINOL - UNII:YUL4LO94HK) RESORCINOL3 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    POTASSIUM CETYL PHOSPHATE (UNII: 03KCY6P7UT)  
    .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    ZEA MAYS (CORN) OIL (UNII: 8470G57WFM)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    TRISODIUM HEDTA (UNII: K3E0U7O8KI)  
    SODIUM SULFATE (UNII: 0YPR65R21J)  
    ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (60000 MPA.S) (UNII: 8Z5ZAL5H3V)  
    GLYCERYL STEARATE (UNII: 230OU9XXE4)  
    LANOLIN (UNII: 7EV65EAW6H)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    ALOE BARBADENSIS LEAF JUICE (UNII: RUE8E6T4NB)  
    AMINOMETHYL PROPANOL (UNII: LU49E6626Q)  
    WATER (UNII: 059QF0KO0R)  
    RETINYL PALMITATE (UNII: 1D1K0N0VVC)  
    ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
    PEG-100 STEARATE (UNII: YD01N1999R)  
    ISOPROPYL PALMITATE (UNII: 8CRQ2TH63M)  
    CHOLECALCIFEROL (UNII: 1C6V77QF41)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:69396-183-011 in 1 BOX05/01/2026
    128.4 g in 1 TUBE; Type 0: Not a Combination Product
    2NDC:69396-183-333 in 1 BOX05/01/2026
    228.4 g in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01704/30/2026
    Labeler - TRIFECTA PHARMACEUTICALS USA LLC (079424163)
    Registrant - Trifecta Pharmaceuticals USA (079424163)